Oleg Noodleman

Investor, EcoR1 Capital · 1 appearance on the record.

computed by AI from the episodes · how this works → · full disclaimer →

Oleg Nodelman is an investor at EcoR1 Capital. He is known for pitching Aktis Oncology.

3statements → 3claims → 1claims resolved → 3/5average certainty → 2.33/5average debate potential →

1 supported 0 partly supported 0 contradicted 2 not checkable as stated how the 3 claims stand · each chip opens the sources

2 predictions · 1 assertion · every statement was checked. The predictions and assertion are the 3 claims: statements the public record can support or contradict. 1 is resolved, and 2 name no date, number or outcome precise enough to check. Everything else (opinions, insights, what ifs, disclosures) can never be settled by the record, so it carries no assessment.

The record, in short

What the tape says about how Oleg argues and how the claims held up. Everything they said, and everything said about them, is in the tabs below.

Their most notable supported claim

Assertion Supported

Nodelman: Aktis Oncology's IPO was 18x oversubscribed, backstopped by Eli Lilly

“Actis was started five years ago, but recently went public with a three hundred million dollar IPO that was 18 times oversubscribed, and backstopped with a hundred million dollar order by Eli Lilly, the folks who bring you all the weight loss drugs.”

Oleg Noodleman Jun 12, 2026 ▶ 31:38 All-In's Best Ideas Pitch Competition: 4 Investors Present Their Top Trades Live

What they said3 Episodes1

Everything Oleg Noodleman said on All-In that made the record, most notable first. Filter by type, assessment or year in the ledger →

Prediction Not checkable as stated

Nodelman: Aktis Oncology could reach a $10B valuation if one program succeeds

“We think Actis could be worth ten billion or 200 dollars per share if even one of their programs makes it to market, and in this case, you have a lot of outs.”

Oleg Noodleman Jun 12, 2026 ▶ 34:33 All-In's Best Ideas Pitch Competition: 4 Investors Present Their Top Trades Live

Prediction Not checkable as stated

Nodelman: Average human lifespan in developed countries will exceed 100 years

“I would take the over on that.”

Oleg Noodleman Jun 12, 2026 ▶ 37:49 All-In's Best Ideas Pitch Competition: 4 Investors Present Their Top Trades Live